Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.
D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D002273:Carcinogens / Q000008:administration & dosage / Q000009:adverse effects; D018736:DNA Adducts / Q000009:adverse effects / Q000096:biosynthesis*; D003625:Data Collection / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004739:England; D005054:Eugenol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000378:metabolism; D005260:Female; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D008297:Male; D010759:Phosphorus Isotopes; D051381:Rats; D011916:Rats, Inbred F344; D017208:Rats, Wistar; D018570:Risk Assessment / Q000379:methods; D013223:Statistics as Topic / Q000379:methods; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration
D002273:Carcinogens; D018736:DNA Adducts; D010759:Phosphorus Isotopes; D013629:Tamoxifen; C005223:methyleugenol; D005054:Eugenol